HEATHER REINHARDT: Open Payments
NPI 1750002309 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: ENTYVIO, NUCALA, GEMTESA, TREMFYA, EOHILIA, IBSRELA, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
